AxoGen, Inc.
NasdaqCM:AXGN
$ 6.04
+ $0.07 (1.17%)
$ 6.04
+ $0.07 (1.17%)
End-of-day quote: 05/17/2024

AXGN: Global investment alternatives & competitors

Competitors

Ticker Price Forecast 1Y Forecast 2Y Market Cap Div Yld Growth Rate
NYSE:SYK
Stryker Corp
334.68 -13.29% -2.71% 127,496.27 0.96% 7.72%
NYSE:BDX
Becton Dickinson and Co
236.30 15.46% 29.59% 68,292.23 1.61% 2.09%
NYSE:BAX
Baxter International Inc
35.25 82.77% 110.35% 17,962.7 3.3% -3.14%
LSE:SN.
Smith & Nephew
10.24 47.14% 71.39% 8,732.55 2.89% -3.85%
NasdaqGS:IART
Integra LifeSciences Holdings
27.54 184.04% 214.71% 1,818.86 0% 5.08%
NasdaqCM:MDXG
MiMedx Group
7.80 0% 0% 1,078.98 0% 0%
NasdaqGS:OFIX
Orthofix Medical
15.00 -,104.96% 203.5% 521.27 0% 0%
NasdaqCM:ORGO
Organogenesis Holdings
2.74 -50.6% 9.77% 401.69 0% -10.61%
NYSEAM:LCTX
Lineage Cell Therapeutics
1.08 0% 0% 220.89 0% 0%
ASX:MSB
Mesoblast
1.09 0% 0% 299.37 0% 0%
NasdaqCM:CGEN
Compugen
2.11 0% 0% 187.12 0% 0%
NYSEAM:XTNT
Xtant Medical Holdings
0.72 0% 0% 103 0% 0%
NasdaqCM:PLUR
Pluri
6.10 0% 0% 32.82 0% 0%
OTCPK:ATHX
Athersys
0.00 0% 0% 0.87 0% 0%
OTCPK:ISCO
International Stem Cell
0.09 0% 0% 0.72 0% 0%
OTCPK:PRED
Predictive Technology Group
0.00 0% 0% 0.03 0% 0%
OTCPK:CRYO
American CryoStem
0.00 0% 0% 0 0% 0%